Please assess the completion status of the following clinical trial:

Trial Title: Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female DEERS-eligible dependent military health care beneficiaries age 8 to 18 years old evaluated by Pediatric Gastroenterology service at WRAMC and are scheduled to undergo a colonoscopy between 1 Sep 2010 - 31 Dec 2011 and do not meet exclusion criteria.~Exclusion Criteria:~* Age less than 8 years or greater than 18 at time of procedure~* Colonic surgery including hemicolectomy, colectomy, ileostomy, or multiple abdominal surgeries.~* Oral aversion or other feeding disorder.~* Inability to drink large amount of liquids.~* Aspiration risk.~* Renal disease or pre-cleanout electrolytes outside normal range.~* Significant cardiovascular disease.~* Allergy to food coloring or polyethylene glycol 3350.~* Inpatient or emergency colonoscopy.~* Current nasogastric tube in place.~* Known Pregnancy. Urine pregnancy test will only be completed on day of colonoscopy for all females age 14 and older per current standard anesthesia protocols. There have been no known reported animal or human studies that report the fetal effects of using polyethylene glycol. Per FDA, it is labeled as a category C drug in pregnancy. However, two studies , have reported successful treatment of constipation during pregnancy using polyethylene glycol solutions and did not find any significant effects or safety issues

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Polyethylene glycol 3350 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).